The efficacy and safety of varenicline alone versus in combination with nicotine lozenges for smoking cessation among hospitalised smokers (VANISH): study protocol for a randomised, placebo-controlled trial

INTRODUCTION: Smoking is a leading cause of premature deaths globally. The health benefits of smoking cessation are many. However, majority of quit attempts are unsuccessful. One way to potentially improve success rates is to evaluate new combinations of existing smoking cessation therapies that may...

Descripción completa

Detalles Bibliográficos
Autores principales: Gobarani, Rukshar Kaizerali, Abramson, Michael J, Bonevski, Billie, Weeks, Gregory R, Dooley, Michael J, Smith, Brian J, Veale, Antony, Webb, Ashley, Kirsa, Sue, Thomas, Dennis, Miller, Alistair, Gasser, Rudi, Paul, Eldho, Parkinson, Jacqueline, Meanger, Darshana, Coward, Lisa, Kopsaftis, Zoe, Rofe, Olivia, Lee, Paula, George, Johnson
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Smoking and Tobacco
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7539569/
https://www.ncbi.nlm.nih.gov/pubmed/33028555
http://dx.doi.org/10.1136/bmjopen-2020-038184

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7539569/
https://www.ncbi.nlm.nih.gov/pubmed/33028555
http://dx.doi.org/10.1136/bmjopen-2020-038184

Ejemplares similares